Genetic analysis of ulcerative colitis-associated colorectal tumors and its relation with genetic polymorphisms

Genetic analysis of ulcerative colitis-associated colorectal tumors and its relation with genetic polymorphisms - Genetic analysis of UCAN

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000058379

Enrollment

231

Registered

2025-07-06

Start date

2025-06-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis-associated neoplasia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ulcerative colitis-associated neoplasia and sporadic colorectal tumors diagnosed and treated at Fujita Health University Hospitals

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Association between tumor-related TP53 genetic abnormalities and genetic polymorphisms in ulcerative colitis-associated neoplasia	—

Secondary

Measure	Time frame
To determine the association between tumor-related genetic abnormalities other than TP53 and genetic polymorphisms in ulcerative colitis-associated neoplasia	—

Countries

Japan

Contacts

Public ContactNaoki Ohmiya

Fujita Health University Hospital Department of Advanced Endoscopy

nohmiya@fujita-hu.ac.jp0562939240

Outcome results